Cetuximab Augments Cytotoxicity with Poly (ADP-Ribose) Polymerase Inhibition in Head and Neck Cancer

Overexpression of the epidermal growth factor receptor (EGFR) is a hallmark of head and neck cancers and confers increased resistance and inferior survival rates. Despite targeted agents against EGFR, such as cetuximab (C225), almost half of treated patients fail this therapy, necessitating novel th...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Nowsheen, Somaira, Bonner, James A., LoBuglio, Albert F., Trummell, Hoa, Whitley, Alexander C., Dobelbower, Michael C., Yang, Eddy S.
Formato: Artigo
Idioma:Inglês
Publicado: Public Library of Science 2011
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3166164/
https://ncbi.nlm.nih.gov/pubmed/21912620
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0024148
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares